Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LEMAITRE VASCULAR INC Director's Dealing 2015

Oct 23, 2015

31708_dirs_2015-10-23_a727f67e-d8bd-4f9c-8dc8-1f7ee48806be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2015-10-22

Reporting Person: Wijas Michael T (VP of Sales, The Americas)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-22 Stock Option (Right to Buy) $12.76 A 11730 Acquired 2022-10-22 Common Stock (11730) Direct

Footnotes

F1: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years.